SLC8A1 and pancreatic neoplasm: CaSR activation markedly suppresses pancreatic tumourigenesis, possibly through sodium-calcium exchanger 1-mediated Ca2+ influx; this leads to the inhibition of Wnt/β-catenin signalling in pancreatic cancer cells25.